Additional file 3 of The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes

Supplementary material 3: Supplementary figure 3. Kaplan-Meier survival curves for (A and C) disease-free and (B and D) overall survival according to the PAT in the TPML (A and B) and TPMH (C and D) groups. TPML, tumors with 5%≤ the proportion of MPP components (TPM) ≤ 10%; TPMH, tumors with TPM greater than 10%; PAT, postoperative adjuvant treatment; non-PAT, observation